Benzinga's Top Pre-Market Gainers

BG Medicine BGMD soared 11.54% to $3.77 in the pre-market trading. BG Medicine obtained a CE Mark enabling the commercial sale of the CardioSCORE(TM) test in the EU. Sucampo Pharmaceuticals SCMP moved up 10.66% to $5.50 in the pre-market session. Sucampo Pharma received approval of an sNDA for RESCULA (unoprostone isopropyl ophthalmic solution) from the FDA. Clearwire CLWR added 5.60% to $2.83 in the pre-market session. Sprint Nextel S is in talks to buy the 49% of Clearwire, according to people familiar with the matter. Oncothyreon ONTY surged 4.58% to $4.80 in the pre-market session. Oncothyreon's trailing-twelve-month ROE is -33.87%.